INIS
patients
100%
control
100%
children
100%
inflammation
100%
burns
50%
energy consumption
50%
size
33%
cytokines
33%
mortality
33%
administration
16%
data
16%
catabolism
16%
medicine
16%
comparative evaluations
16%
interleukins
16%
hospitals
16%
length
16%
pediatrics
16%
distribution
16%
guidelines
16%
tumor necrosis factor
16%
colonies
16%
Medicine and Dentistry
Child
100%
Propranolol
100%
Inflammation
100%
Sepsis
100%
Patient
41%
Infection
33%
Resting Energy Expenditure
25%
Age
16%
Cytokine
16%
Gender
16%
Incidence
16%
Hypermetabolism
16%
Mortality
16%
Serum
16%
Therapeutic Procedure
8%
Analysis
8%
Thermal Burn
8%
Catabolism
8%
Serositis
8%
Tumor Necrosis Factor
8%
Hospital
8%
Immune Function
8%
Intensive Care Medicine
8%
Interleukin 1
8%
Pediatrics Patient
8%
Fibrinogen
8%
Intention-to-Treat Analysis
8%
Immunology and Microbiology
Resting Energy Expenditure
100%
Inflammation
100%
Incidence
66%
Cytokine
66%
Mortality
66%
Age
66%
Gender
66%
Catabolism
33%
Inflammation Response
33%
Tumor Necrosis Factor Alpha
33%
Length
33%
Interleukin 1
33%
Pharmacology, Toxicology and Pharmaceutical Science
Propranolol
100%
Inflammation
100%
Sepsis
100%
Infection
33%
Cytokine
16%
Mortality
16%
Hypermetabolism
16%
Incidence
16%
Burn
8%
Tumor Necrosis Factor
8%
Interleukin 1
8%
Fibrinogen
8%
Neuroscience
Propranolol
100%
Resting Energy Expenditure
25%
Pediatrics
8%
Tumor Necrosis Factor Alpha
8%
Interleukin 1
8%
Catabolism
8%
Intention
8%
Fibrinogen
8%
Veterinary Science and Veterinary Medicine
Propranolol
100%
Cytokines
16%
Tumor Necrosis Factor
8%
Interleukin-1
8%